RedixFi
RedixFi

KIMS · Concall Summary

KRISHNA INST OF MED SCI L

Concall2026-08-08
Tone: Positive

The earnings conference call for KIMS Hospitals on August 4, 2026, highlighted strong financial performance for Q1 FY '27, with total revenue reported at INR 1,196 crore, reflecting a year-on-year growth of 36.1%. EBITDA was INR 240 crore, marking a 20.1% increase year-on-year. Management noted a successful Qualified Institutional Placement (QIP) that raised INR 1,500 crore, with INR 1,100 crore already utilized to reduce debt. The company opened a new unit in Kerala and reported positive operational metrics, including a 26.6% increase in inpatient volumes. Management emphasized the importance of stabilizing existing hospitals and achieving EBITDA positivity across new units. They also discussed ongoing empanelment efforts with insurance companies and the potential for future growth in core markets. Overall, management conveyed optimism about the company's trajectory and commitment to quality care.

Management emphasized strong growth and operational success.

View source filing →

Earlier concalls

  • 2026-08-03The investor presentation from Krishna Institute of Medical Sciences Limited (KIMS) dated August 3, 2026, outlines the c
  • 2026-05-22On May 18, 2026, KIMS Hospitals held its Q4 FY '26 earnings conference call, where management reported a total revenue o
  • 2026-05-16On May 16, 2026, Krishna Institute of Medical Sciences Limited (KIMS) submitted an investor presentation detailing its a

See KIMS's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.

Sign up free

Back to KIMS snapshot

KRISHNA INST OF MED SCI L (KIMS) — Latest Concall Summary · RedixFi